Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedJan 02, 2026
DataAggregated Company Financials
Companies10
  • 7D-2.2%
  • 3M-11.5%
  • 1Y-7.8%
  • YTDn/a

Over the last 7 days, the Life Sciences industry has dropped 2.2%, driven by declines in HeXun Biosciences and EirGenix of 10.0% and 1.4%, respectively. However, the industry is down 7.5% over the past year.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 02 Jan 2026NT$33.9bNT$2.4b-NT$689,929,000.0025.8x-49.2x14x
Sun, 30 Nov 2025NT$37.9bNT$2.4b-NT$670,921,000.0019.9x-56.5x15.5x
Tue, 28 Oct 2025NT$36.3bNT$2.5b-NT$870,437,000.0018.5x-41.7x14.8x
Thu, 25 Sep 2025NT$35.3bNT$2.5b-NT$870,437,000.0019.8x-40.5x14.4x
Sat, 23 Aug 2025NT$35.6bNT$2.5b-NT$819,216,000.0020.6x-43.5x14.5x
Mon, 21 Jul 2025NT$34.4bNT$2.5b-NT$600,003,000.0022.3x-57.4x14x
Wed, 18 Jun 2025NT$32.9bNT$2.5b-NT$600,003,000.0023.5x-54.9x13.4x
Fri, 16 May 2025NT$31.8bNT$2.5b-NT$604,301,000.0023.3x-52.6x13x
Sun, 13 Apr 2025NT$30.7bNT$2.5b-NT$540,128,000.0023.4x-56.9x12.5x
Tue, 11 Mar 2025NT$36.3bNT$2.6b-NT$854,432,000.0024.6x-42.5x14.2x
Thu, 06 Feb 2025NT$37.2bNT$2.6b-NT$854,432,000.0024x-43.5x14.5x
Sat, 04 Jan 2025NT$34.5bNT$2.6b-NT$854,432,000.0022.8x-40.4x13.5x
Mon, 02 Dec 2024NT$42.2bNT$2.6b-NT$854,432,000.0023.7x-49.4x16.5x
Wed, 30 Oct 2024NT$42.1bNT$2.5b-NT$712,402,000.0024.5x-59x16.7x
Fri, 27 Sep 2024NT$41.2bNT$2.3b-NT$836,610,000.0022.3x-49.3x18.1x
Sun, 25 Aug 2024NT$40.9bNT$2.3b-NT$836,610,000.0022.3x-48.9x18x
Tue, 23 Jul 2024NT$42.7bNT$2.1b-NT$797,765,000.0033.2x-53.5x20x
Thu, 20 Jun 2024NT$41.5bNT$2.1b-NT$797,765,000.0034.3x-52x19.4x
Sat, 18 May 2024NT$40.7bNT$2.1b-NT$893,893,000.0032.1x-45.6x19.1x
Mon, 15 Apr 2024NT$40.9bNT$2.1b-NT$903,875,000.0030.9x-45.3x19.4x
Wed, 13 Mar 2024NT$40.5bNT$2.1b-NT$611,249,000.0032.8x-66.3x19.7x
Fri, 09 Feb 2024NT$43.0bNT$2.1b-NT$610,218,000.0032.4x-70.4x20.7x
Sun, 07 Jan 2024NT$46.5bNT$2.1b-NT$610,218,000.0034.4x-76.3x22.4x
Tue, 05 Dec 2023NT$49.7bNT$2.1b-NT$610,218,000.0034.9x-81.4x23.9x
Thu, 02 Nov 2023NT$49.0bNT$2.2b-NT$497,769,000.0031.6x-98.5x22x
Sat, 30 Sep 2023NT$48.0bNT$2.2b-NT$497,769,000.0031.3x-96.4x21.6x
Mon, 28 Aug 2023NT$43.1bNT$2.2b-NT$497,769,000.0031.3x-86.7x19.4x
Wed, 26 Jul 2023NT$49.0bNT$2.5b-NT$274,767,000.0042.3x-178.2x20x
Fri, 23 Jun 2023NT$48.4bNT$2.5b-NT$274,767,000.0043.2x-176.1x19.7x
Sun, 21 May 2023NT$50.1bNT$2.6b-NT$38,534,000.0041.9x-1299x19.1x
Tue, 18 Apr 2023NT$50.6bNT$2.7b-NT$29,761,000.0024.7x-1700.3x19x
Thu, 16 Mar 2023NT$48.2bNT$2.7bNT$82.4m24x585.8x18.2x
Sat, 11 Feb 2023NT$52.8bNT$2.7bNT$85.3m19.8x619x19.7x
Mon, 09 Jan 2023NT$47.8bNT$2.7bNT$85.3m18.6x560.2x17.9x
Price to Earnings Ratio

560.2x


Total Market Cap: NT$47.8bTotal Earnings: NT$85.3mTotal Revenue: NT$2.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Life Sciences Industry Price to Earnings3Y Average -116.5x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.6x is higher than the industry's current PS ratio of 14.0x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 3.1% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market2.14%
Healthcare-0.93%
Life Sciences-2.20%
Clinical Research and Equipment-2.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6939 TFBS BioscienceNT$21.404.4%
+NT$31.4m
-24.1%n/a

Latest News